NCT02968810 2026-04-13
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
11 trialsNCT02197234 2025-11-20
Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC
AstraZeneca
Phase 1 Completed
NCT02096588 2024-07-09
Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT03454529 2023-08-01
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed
NCT02061397 2020-08-25
SOS
University of Pennsylvania
Phase 1/2 Completed
NCT01772719 2019-11-18
Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
University of Louisville
Phase NA Terminated
NCT00334542 2019-04-03
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00572468 2017-07-13
Statin Therapy Versus Placebo Prior to Prostatectomy
VA Office of Research and Development
Phase NA Completed
NCT00656292 2017-05-19
Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery
Mayo Clinic
Phase 4 Completed
NCT00575965 2015-12-16
Simvastatin in Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT00354640 2013-06-24
Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed